Symptoms
Best of the west: meet PSA’s newest award winners
Four pharmacists were crowned the best of the west at PSA’s West Australian Annual Therapeutic Update (ATU) last weekend.
Expect an increase in demand for long-acting injectable buprenorphine
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
Report any CAM adverse effects, warns Dr Geraldine Moses
Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.
The trial that could revolutionise medicine safety
Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.
Pharmacists scramble to protect remote communities from COVID-19
Clusters of infection in regional and remote areas continue to grow, with overworked pharmacists adapting their services to minimise the spread.
Sole pharmacists: Out on one’s own
Australia’s cities hug the coast, but in rural and remote areas, sole pharmacists are providing communities with an essential service. Some may think it’s...
